Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Antimicrobial Agents|January 15, 2019
Posaconazole trough concentrations are not influenced by inflammation: A prospective studyAnne-Grete Märtson, Anette Veringa, Martijn Bakker, et al.
Current Pharmaceutical Design|December 15, 2017
The Role of PET in Monitoring Therapy in Fungal InfectionsAlfred O Ankrah, Hans C Klein, Lambert F R Span, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2019
Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life: Results in Dutch Patients and Review of the LiteratureStefanie Slot, Reinier A P Raymakers, Nicolaas Schaap, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 22, 2018
Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infectionsAlfred O Ankrah, Lambert F R Span, Hans C Klein, et al.
Clinical Chemistry|December 11, 2023
Hereditary Alpha Tryptasemia: Validation of a Single-Well Multiplex Digital Droplet PCR Assay in a Cohort of Symptomatic PatientsAbdulrazzaq Alheraky, Albertus T J Wierenga, Arjan Simpelaar, et al.
Therapeutic Drug Monitoring|February 5, 2016
Voriconazole Therapeutic Drug Monitoring Practices in Intensive CareMarjolijn J P van Wanrooy, Michael G G Rodgers, Lambert F R Span, et al.
The Journal of Antimicrobial Chemotherapy|September 8, 2016
Voriconazole metabolism is influenced by severe inflammation: a prospective studyAnette Veringa, Mendy Ter Avest, Lambert F R Span, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2013
Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole, and posaconazoleKim C M van der Elst, Lambert F R Span, Kai van Hateren, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
Inflammation is associated with voriconazole trough concentrationsMarjolijn J P van Wanrooy, Lambert F R Span, Michael G G Rodgers, et al.
Pageof 3